Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Alzheimer's Disease Therapeutics and Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Biomarkers
  • 1.4.3 Cholinesterase inhibitors
  • 1.4.4 NMDA receptor antagonists
  • 1.4.5 Brain imaging
  • 1.4.6 Blood tests
• 1.5 Market by Application
  • 1.5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Drugs Market
  • 1.5.3 Diagnostics Market
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2015-2026)
• 2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Regions
  • 2.2.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Alzheimer's Disease Therapeutics and Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Alzheimer's Disease Therapeutics and Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Market Size
  • 3.1.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio
  • 3.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2019
• 3.3 Alzheimer's Disease Therapeutics and Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
• 3.5 Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 6.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 7.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 8.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in China (2019-2020)
• 8.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 8.4 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 9.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 10.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 11.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in India (2019-2020)
• 11.3 India Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 11.4 India Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 12.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Namenda
  • 13.1.1 Namenda Company Details
  • 13.1.2 Namenda Business Overview
  • 13.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020))
  • 13.1.5 Namenda Recent Development
• 13.2 Aricept
  • 13.2.1 Aricept Company Details
  • 13.2.2 Aricept Business Overview
  • 13.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.2.5 Aricept Recent Development
• 13.3 Exelon
  • 13.3.1 Exelon Company Details
  • 13.3.2 Exelon Business Overview
  • 13.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.3.5 Exelon Recent Development
• 13.4 Solanezumab
  • 13.4.1 Solanezumab Company Details
  • 13.4.2 Solanezumab Business Overview
  • 13.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.4.5 Solanezumab Recent Development
• 13.5 Gantenerumab
  • 13.5.1 Gantenerumab Company Details
  • 13.5.2 Gantenerumab Business Overview
  • 13.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.5.5 Gantenerumab Recent Development
• 13.6 Verubecestat
  • 13.6.1 Verubecestat Company Details
  • 13.6.2 Verubecestat Business Overview
  • 13.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.6.5 Verubecestat Recent Development
• 13.7 Pfizer
  • 13.7.1 Pfizer Company Details
  • 13.7.2 Pfizer Business Overview
  • 13.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.7.5 Pfizer Recent Development
• 13.8 Eisai
  • 13.8.1 Eisai Company Details
  • 13.8.2 Eisai Business Overview
  • 13.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.8.5 Eisai Recent Development
• 13.9 Actavis
  • 13.9.1 Actavis Company Details
  • 13.9.2 Actavis Business Overview
  • 13.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.9.5 Actavis Recent Development
• 13.10 Lundbeck
  • 13.10.1 Lundbeck Company Details
  • 13.10.2 Lundbeck Business Overview
  • 13.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 13.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.10.5 Lundbeck Recent Development
• 13.11 Daiichi Sankyo
  • 10.11.1 Daiichi Sankyo Company Details
  • 10.11.2 Daiichi Sankyo Business Overview
  • 10.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 10.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 10.11.5 Daiichi Sankyo Recent Development
• 13.12 Novartis
  • 10.12.1 Novartis Company Details
  • 10.12.2 Novartis Business Overview
  • 10.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 10.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 10.12.5 Novartis Recent Development
• 13.13 TauRx
  • 10.13.1 TauRx Company Details
  • 10.13.2 TauRx Business Overview
  • 10.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction
  • 10.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
  • 10.13.5 TauRx Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer